GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Hash Corp (XCNQ:REZN) » Definitions » EBITDA Margin %

The Hash (XCNQ:REZN) EBITDA Margin % : -62.62% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is The Hash EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. The Hash's EBITDA for the three months ended in Dec. 2023 was C$-0.07 Mil. The Hash's Revenue for the three months ended in Dec. 2023 was C$0.11 Mil. Therefore, The Hash's EBITDA margin for the quarter that ended in Dec. 2023 was -62.62%.


The Hash EBITDA Margin % Historical Data

The historical data trend for The Hash's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Hash EBITDA Margin % Chart

The Hash Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
- - -547.40 -151.24 -48.01

The Hash Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -74.47 -3.45 -119.47 -43.51 -62.62

Competitive Comparison of The Hash's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, The Hash's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Hash's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Hash's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where The Hash's EBITDA Margin % falls into.



The Hash EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

The Hash's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.266/0.554
=-48.01 %

The Hash's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.067/0.107
=-62.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Hash  (XCNQ:REZN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


The Hash EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of The Hash's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


The Hash (XCNQ:REZN) Business Description

Traded in Other Exchanges
Address
1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
The Hash Corp is engaged in the production and sale of cannabis-based hashish and other cannabis products. It applies its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additive and carcinogenic solvents.

The Hash (XCNQ:REZN) Headlines

No Headlines